Amicus Therapeutics is Changing Lives for People Who Have Diseases and Disorders that are Uncommon

Amicus is the American biopharmaceutical company that is located in Cranbury, New Jersey. Amicus Therapeutics went public back in the year 2007 where they operated under the NASDAQ symbol of FOLD. This business was created by many venture capital firms which included the firm Radius Ventures(Yahoo Finance). It also worked alongside of New Enterprise Associates.

The therapeutic focus for the business is surrounding orphan and rare diseases. It works to create a plan on different therapy options for various diseases and in 2014, the business was said to have the largest portfolio for small molecules within the pharmacological chaperones within the industry of pharmaceuticals.

There are a number of diseases out there that leaves patients without hope that they can be cured or treated. A specific example is of Fabry Disease. This disease is a genetic disorder and to help people overcome the disease, the latest product of Amicus Therapeutics is Migalastat. By creating a number of enzyme replacement therapies, patients who suffer from this disease are able to see a difference in their lives.

The goal of Amicus Therapeutics is to help patients who are suffering from a disease to live longer and healthier lives by allowing therapies to work to alleviate the symptoms of various diseases. They are very passionate and the work they are doing and are always thinking of different things to do to help patients. As long as they continue to push the idea of each therapy and to take a number of risks that will push for different advances to be made, more patients are able to be helped when they suffer from a genetic disorder or disease.

The goal of the company is to think outside of the box and to keep asking the questions that are the hardest to answer. The business knows that in order to make a difference, they have to know and understand the mistakes that have been made. Once you understand a mistake and know how to avoid it, you start to learn how to avoid it and bypass it the next time. It encourages more hope and promise which is what patients need when they suffer from a disease or disorder.

Check out Amicus Therapeutics on Twitter and Facebook

How Flavio Maluf Experience is Key to Growth at Eucatex

Flavio Maluf serves as the president and chief executive officer of Eucatex, a Brazilian company that has interests in the construction and manufacturing industry. He has been working in the family-owned business for close to three decades. During this period, he has served in several departments, something that has made him to have an understanding about the firm’s operations. Since becoming the company’s president, Mr. Maluf has been focusing on modernizing operations to enable it meet the needs of the market.

Flavio is an alumnus of Fundação Armando Alvares Penteado from where he holds a mechanical engineering degree. In addition, he studied finance, trade, and commerce at New York University. While living and studying in New York, Flavio had the opportunity to work at several multinationals. Coming back to Brazil, his experience helped shape his impressive managerial career. He rose through the ranks to be appointed to the firm’s executive board before ascending to the presidency. He has served in that capacity for nearly ten years. During this time, the company has experienced massive success.

Career Highlights

As company president, Flavio’s main focus has been streamlining and modernizing operations. Through his efforts, the company has been able to add new products and services to its portfolio. The company’s management structure has similarly been changed, something that has made Eucatex more efficient and profitable. It is currently ranked among the largest corporations in Brazil. Notable acquisitions have been made during Flavio’s stint at the helm. In addition, the company has acquired several factories in an ambitious expansion move.

About Eucatex

The company has been in operation for more than 61 years. It is involved in the production and marketing of insulators and liners made from eucalyptus. It mainly serves the construction and furniture sectors. It supplies modular partitions, paints, and laminate doors to the construction industry. The company’s products are manufactured in a meticulous process to ensure that they meet the highest quality. Its products are exported to more than 37 countries. Since Flavio ascended to the presidency, Eucatex has been registering massive profits. The company has also been sponsoring several community-based initiatives in Sao Paolo and other Brazilian cities.